Status:
ENROLLING_BY_INVITATION
The Influence of Treatment Format on Schema Therapy for Borderline Personality Disorder
Lead Sponsor:
University of Amsterdam
Collaborating Sponsors:
Academic Center for Trauma and Personality
Arkin Mental Health Care
Conditions:
Borderline Personality Disorder
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to compare etc. in patients with borderline personality disorder pure individual schema therapy to combined individual-group schema therapy. The main questions it ai...
Detailed Description
Schema Therapy (ST) for Borderline Personality Disorder (BPD) was originally developed and tested as an individual treatment. Since 2009 group-ST became popular as an supposedly efficient alternative....
Eligibility Criteria
Inclusion
- BPD as defined by the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5), assessed with the Structured Clinical Interview for the DSM-5 Personality Disorders (SCID-5-PD), as primary diagnosis
- BPDSI total score ≥ 20 (i.e, severity in the BPD range, Giesen-Bloo et al., 2010)
- Ability to understand, read, write and speak Dutch, or English if the site has research assistants and therapists of both conditions that are sufficiently fluent in English, as well as an English ST group (as at ACTP).
Exclusion
- DSM-5 substance use disorder that needs clinical detox according to the clinical staff (after 6 weeks of abstinence participation is possible).
- Comorbid psychotic disorder (patients with temporary psychotic problems falling under BPD criterion 9 are not excluded)
- DSM-5 Bipolar disorder, type 1 (current or past)
- Acute suicide risk
- Intelligence Quotient (IQ) \< 80
- Serious neurological problems such as dementia
- Patients should not start with any form of psychological treatment during screening or during the study's waitlist or treatment. (Low frequency supportive treatment may be continued during wait and screening, but not during the study treatment.)
- Not able or willing to plan participation in the treatment sessions. Note 1. In case of suspicion of exclusion criteria that need specific assessment, like IQ and dementia, a formal diagnostic assessment needs to be done before in/exclusion can be decided.
- Note 2. No other psychological treatment during the study follow-up period is provided, unless this is necessary (clinical judgment). The 1 year treatment-free follow-up period is part of the treatment protocol, to help patients gain experience with life without mental health care. After 1 year further treatment can be offered, if indicated.
Key Trial Info
Start Date :
November 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2027
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT05986552
Start Date
November 10 2023
End Date
December 30 2027
Last Update
January 20 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Academic Center for Trauma and Personality ACTP
Amsterdam, Netherlands, 1001NK
2
Arkin Mental Health Care
Amsterdam, Netherlands, 1093 MB